Robert Ross Carter - 06 Jan 2025 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Role
Chief Financial Officer
Signature
/s/ Mark Hueppelsheuser, Attorney-in-fact for Robert Carter
Issuer symbol
TOI
Transactions as of
06 Jan 2025
Net transactions value
-$86.43
Form type
4
Filing time
07 Jan 2025, 13:18:13 UTC
Previous filing
21 Nov 2024
Next filing
20 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TOI Class A Common Stock Disposed to Issuer $86.43 -258 -0.81% $0.3350 31,501 06 Jan 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement.
F2 Price is the volume weighted average selling price of all sales by the Reporting Person on January 6, 2025 within a one-dollar range. Actual prices ranged from $0.293 to $0.335. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.